During the past decade, National Institute of Neurological Disorders and Stroke (NINDS) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Neurological Disorders and Stroke (NINDS)" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "University of Pittsburgh" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Neurological Disorders and Stroke (NINDS)" are "Healthy" (49 trials), "Parkinson Disease" (16 trials), "Cerebrovascular Accident" (13 trials), "Epilepsy" (9 trials) and "Parkinson's Disease" (9 trials). Many other conditions were trialed in "National Institute of Neurological Disorders and Stroke (NINDS)" in a lesser frequency.

Most popular intervention types in "National Institute of Neurological Disorders and Stroke (NINDS)" are "Drug" (54 trials), "Device" (12 trials), "Procedure" (12 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "IV Levodopa" (5 trials), "Replagal" (3 trials), "0-15 Water" (2 trials), "1-Octanol" (2 trials) and "15 O Water" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Neurological Disorders and Stroke (NINDS)" are 172 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Neurological Disorders and Stroke (NINDS)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 176 completed trials in National Institute of Neurological Disorders and Stroke (NINDS), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Neurological Disorders and Stroke (NINDS), 18 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".